From: Serum protein S-100B as a novel biomarker of diagnosis and prognosis of childhood epilepsy
Age | Group | T-Test | ||
---|---|---|---|---|
Patient | Control | t | P-value | |
Range | 1–16 | 1–15 | 1.075 | 0.285 |
Mean ± SD | 7.133 ± 3.539 | 6.400 ± 2.903 |
Gender | Group | Chi-square | ||||
---|---|---|---|---|---|---|
Patient | Control | |||||
n | % | n | % | X2 | P-value | |
Male | 31 | 68.89 | 27 | 60.00 | 0.776 | 0.378 |
Female | 14 | 31.11 | 18 | 40.00 | ||
Total | 45 | 100.00 | 45 | 100.00 |
n | % | |
---|---|---|
Classification of epilepsy | ||
Generalized | 32 | 71.11 |
Focal | 13 | 28.89 |
Total | 45 | 100.00 |
Severity | ||
Mild | 14 | 31.11 |
Moderate | 15 | 33.33 |
Severe | 16 | 35.56 |
Total | 45 | 100.00 |
EEG localization | ||
Generalized | 31 | 68.89 |
Temporal | 9 | 20.00 |
Frontal | 3 | 6.67 |
Central | 2 | 4.44 |
Total | 45 | 100.00 |
MRI | ||
Normal MRI | 34 | 75.56 |
Abnormal MRI | 11 | 24.44 |
Total | 45 | 100.00 |